Cumberland Pharmaceuticals CPIX Line of Credit Outstanding
Line of Credit Outstanding at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LongTermLineOfCredit.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's line of credit outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's line of credit outstanding?
- Cumberland Pharmaceuticals (CPIX) reported line of credit outstanding of $5.24M in Q1 2026.
- What is the long-term trend for Cumberland Pharmaceuticals's line of credit outstanding?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's line of credit outstanding has grown at a -19.0% compound annual growth rate (CAGR), from $15M to $5.24M.
- What does line of credit outstanding mean?
- This metric represents the total principal amount currently drawn and unpaid under a company's revolving credit facility or similar short-term debt arrangements. It serves as a key indicator of a company's reliance on external financing to manage working capital requirements and short-term liquidity needs. Monitoring this balance helps investors assess the company's financial flexibility and its capacity to fund ongoing operations or strategic initiatives through debt.